Amylyx Pharmaceuticals (AMLX) insider trading in the last 6 months
One insider bought $51K, 5 sold $2.9M.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Amylyx Pharmaceuticals
Questions about AMLX's insider trades
Are AMLX insiders buying or selling?
One insider bought $51K across 1 filing, and 5 insiders sold $2.9M across 10 filings, in the last 6 months. The newest filing: Joshua B. Cohen, Co-Chief Executive Officer, sold $950K on Sep 10, 2026.
Who are AMLX's biggest insider sellers?
By the dollars of their sales in the last 6 months: Joshua B. Cohen (Co-Chief Executive Officer), 2 sales; Justin B. Klee (Co-Chief Executive Officer), 2 sales; James M. Frates (Chief Financial Officer), 2 sales. 5 insiders sold in all.
When did an AMLX insider last buy?
Karen Firestone, Director, bought AMLX shares on May 21, 2026, filed May 26, 2026, the newest insider buy on record.
Amylyx Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.